CAV1 also interacts with other proteins to affect glioma cancer progression, it interacts with TRAF4, an E3 ubiquitin ligase, to maintain its deubiquitylation and stability, thus driving glioma stemness and Temozolomide resistance [40]. This evidence concerns the gene CAV1 and glioma.